About: Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.18 (-71.15%)
ZURA NASDAQ Zura Bio Limited Class A Ordinary Shares
Zura Bio Limited Class A Ordinary Shares share price
ZURA price activity
Last Price
$1.180
Change (24hr)
-2.91 USD (71.15%)
Volume
54.21M
Volume (4w avg)
-
Open
$1.26
Day Range
$0.93 - $1.27
Previous Close
$4.09
Last Trade
09 Nov, 7:14 pm GMT+0
Delayed
09 Nov, 7:14 pm GMT+0
ZURA price performance
Delayed
09 Nov, 7:14 pm GMT+0
ZURA details
ZURA Market Signals